Press release
Dermatology Drugs Market By Growth Factors and Key Players: Allergan Plc, Valeant Pharmaceuticals, Dermira Inc, Aclaris Therapeutics, Inc, AnaptysBio, Inc, Revance Therapeutics, Foamix Pharmaceuticals, Novan, Inc, Sienna Biopharmaceuticals
Dermatology Drugs Market
“Dermatology Drugs Market by Therapeutic Area Segments (Atopic Dermatitis, Psoriasis, Acne, Rosacea), Acne Drug Types (Doxycycline, Absorica, Clindamycin, Myorisan, Aczone, Epiduo) Marketed Therapies (Biologics, Oral Drugs, Topical Drugs), by Approves Treatments (Etanercept (Enbrel), Infliximab (Remicade), Adalimumab (Humira), Ustekinumab (Stelara), Secukinumab (Cosentyx), Ixekizumab (Taltz), Golimumab (Simponi), Brodalumab (Siliq), Guselkamab (Tremfya) and Others) and by Regions (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) - Global Forecasts to 2022"- a Report by Polaris Market Research
Request for a sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/dermatology-drugs-market/request-for-free-sample
The Global Dermatology drugs market was valued at USD 21.32 billion in 2017 as reported by Polaris Market Research. The market is primed to exhibit strong commercial opportunity driven by psoriasis, atopic dermatitis, and aesthetic dermatology indications. The market expansion in dermatology is fueled by the addition of improved formulations of approved treatments in acne and rosacea and the approval of several biologics in psoriasis in recent times. The dermatology is a large but fragmented market opportunity and there remains the significant unmet need for safer and cost-effective treatment options.
The psoriasis market remains the largest and the most promising segment within the broader dermatology category. The psoriasis market is poised to increase from USD 4.08 billion in 2017 to over USD 4.86 billion in 2022 driven by increased penetration of anti-TNFs and the recent market launch of a wave of next-generation biologics led by interleukin (IL-17) class.
There remains significant unmet need to treat moderate to severe atopic dermatitis due to limited effective and long-term therapeutic options. Acne infected population is substantially large and Polaris estimates the market to reach USD 8.47 billion by 2022. Atopic Dermatitis was the largest therapeutic area segment in 2017. And, Polaris estimates that this segment is projected to increase at a CAGR of 3.9% from 2018 to 2022.
Browse Complete Summary of this report @ https://www.polarismarketresearch.com/industry-analysis/dermatology-drugs-market/
Polaris Market Research estimates the acne at over USD 6.8 billion in 2017. The key prescription treatments for acne include topical retinoids, topical and oral antimicrobials, and oral isotretinoin. The non-prescription market for acne is more attractive commercially and is expected to almost double the size of the prescription market by 2022. Topical therapies dominate acne treatment and hold the majority of the market share. Several promising drugs are currently in clinical development in the treatment of acne. Key among them includes Foamix’s FMX-101, the first topical minocycline that demonstrated positive results in the Phase III study. Dermira’s DRM01 remains the first topical sebum inhibitor which demonstrated improved efficacy in Phase II trials. The Phase III study results in adult and adolescent acne patients are expected to read out in 2018.
Geographically, the U.S. remained the single largest market followed by Europe and Japan. The largest market size of the U.S. is attributable to rising adoption of high-priced biologics. The penetration of biologics in the U.S. for dermatological indication especially in psoriasis is still below 10% and the market continues to remain underpenetrated.
Polaris Market Research has modelled forecast market sales of Dermatology drugs from 2016-2022. The key therapeutic segments which have been investigated in the global market from 2016-2022 are:
• Market Analysis by Key Therapeutic Indications
• Market Analysis by Leading and Emerging Approved Treatment Types
• Market Analysis by Marketed Drugs
• Market Analysis by Geographic Regions
Make Inquiry about this report @ https://www.polarismarketresearch.com/industry-analysis/dermatology-drugs-market/inquire-before-buying
Leading Companies investigated in the Report are:
1. Allergan Plc
2. Valeant Pharmaceuticals
3. Dermira Inc
4. Aclaris Therapeutics, Inc
5. AnaptysBio, Inc
6. Revance Therapeutics
7. Foamix Pharmaceuticals
8. Novan, Inc
9. Sienna Biopharmaceuticals
10. Pfizer
11. Sanofi
12. Galderma
13. Leo Pharma
14. Roviant Sciences
15. Otsuka Pharmaceuticals
Key Segments
Therapeutic Area Segments
• Atopic Dermatitis
• Psoriasis
• Acne
• Rosacea
Acne Drug Segments
• Doxycycline
• Absorica
• Clindamycin
• Myorisan
• Aczone
• Epiduo
Marketed Therapies Segments
• Biologics
• Oral Drugs
• Topical Drugs
Approved Treatments Segments
• Etanercept (Enbrel)
• Infliximab (Remicade)
• Adalimumab (Humira)
• Ustekinumab (Stelara)
• Secukinumab (Cosentyx)
• Lxekizumab (Taltz)
• Golimumab (Simponi)
• Brodalumab (Siliq)
• Guselkamab (Tremfya)
• Others
Get customization report @ https://www.polarismarketresearch.com/industry-analysis/dermatology-drugs-market/request-for-customization
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.
Contact us
Mr. Neel
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: neel@polarismarketresearch.com
Web: www.polarismarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dermatology Drugs Market By Growth Factors and Key Players: Allergan Plc, Valeant Pharmaceuticals, Dermira Inc, Aclaris Therapeutics, Inc, AnaptysBio, Inc, Revance Therapeutics, Foamix Pharmaceuticals, Novan, Inc, Sienna Biopharmaceuticals here
News-ID: 1341691 • Views: …
More Releases from Polaris Market Research & Consulting
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of …
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. It…
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 …
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 3.82 billion in 2024 and is expected to…
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin …
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billion…
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 …
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 31.67 billion in 2024 and is expected to reach…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
